Global Neuropeptide Y Receptor Market Insights and Forecast to 2026

Publisher Name :
Date: 04-Aug-2020
No. of pages: 119
Inquire Before Buying

Neuropeptide Y Receptor market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Neuropeptide Y Receptor market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Neuropeptide Y Receptor market is segmented into

- Food Grade

- Pharmaceutical Grade

Segment by Application, the Neuropeptide Y Receptor market is segmented into

- Medicine

- Food Additives

- Others

Regional and Country-level Analysis

The Neuropeptide Y Receptor market is analysed and market size information is provided by regions (countries).

The key regions covered in the Neuropeptide Y Receptor market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Neuropeptide Y Receptor Market Share Analysis

Neuropeptide Y Receptor market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Neuropeptide Y Receptor business, the date to enter into the Neuropeptide Y Receptor market, Neuropeptide Y Receptor product introduction, recent developments, etc.

The major vendors covered:

- Gila Therapeutics

- Novo Nordisk

- XL-protein

- Lilly Eli

- Novartis

- Pfizer

- Merck & Co

- Mannkind

- Gilead Sciences

- Genentech

Global Neuropeptide Y Receptor Market Insights and Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Neuropeptide Y Receptor Product Introduction
1.2 Market Segments
1.3 Key Neuropeptide Y Receptor Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Neuropeptide Y Receptor Market Size Growth Rate by Type
1.4.2 Food Grade
1.4.3 Pharmaceutical Grade
1.5 Market by Application
1.5.1 Global Neuropeptide Y Receptor Market Size Growth Rate by Application
1.5.2 Medicine
1.5.3 Food Additives
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Neuropeptide Y Receptor Market Size, Estimates and Forecasts
2.1.1 Global Neuropeptide Y Receptor Revenue 2015-2026
2.1.2 Global Neuropeptide Y Receptor Sales 2015-2026
2.2 Global Neuropeptide Y Receptor, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Neuropeptide Y Receptor Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Neuropeptide Y Receptor Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Neuropeptide Y Receptor Competitor Landscape by Players
3.1 Neuropeptide Y Receptor Sales by Manufacturers
3.1.1 Neuropeptide Y Receptor Sales by Manufacturers (2015-2020)
3.1.2 Neuropeptide Y Receptor Sales Market Share by Manufacturers (2015-2020)
3.2 Neuropeptide Y Receptor Revenue by Manufacturers
3.2.1 Neuropeptide Y Receptor Revenue by Manufacturers (2015-2020)
3.2.2 Neuropeptide Y Receptor Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Neuropeptide Y Receptor Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Neuropeptide Y Receptor Revenue in 2019
3.2.5 Global Neuropeptide Y Receptor Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Neuropeptide Y Receptor Price by Manufacturers
3.4 Neuropeptide Y Receptor Manufacturing Base Distribution, Product Types
3.4.1 Neuropeptide Y Receptor Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Neuropeptide Y Receptor Product Type
3.4.3 Date of International Manufacturers Enter into Neuropeptide Y Receptor Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Neuropeptide Y Receptor Market Size by Type (2015-2020)
4.1.1 Global Neuropeptide Y Receptor Sales by Type (2015-2020)
4.1.2 Global Neuropeptide Y Receptor Revenue by Type (2015-2020)
4.1.3 Neuropeptide Y Receptor Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Neuropeptide Y Receptor Market Size Forecast by Type (2021-2026)
4.2.1 Global Neuropeptide Y Receptor Sales Forecast by Type (2021-2026)
4.2.2 Global Neuropeptide Y Receptor Revenue Forecast by Type (2021-2026)
4.2.3 Neuropeptide Y Receptor Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Neuropeptide Y Receptor Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Neuropeptide Y Receptor Market Size by Application (2015-2020)
5.1.1 Global Neuropeptide Y Receptor Sales by Application (2015-2020)
5.1.2 Global Neuropeptide Y Receptor Revenue by Application (2015-2020)
5.1.3 Neuropeptide Y Receptor Price by Application (2015-2020)
5.2 Neuropeptide Y Receptor Market Size Forecast by Application (2021-2026)
5.2.1 Global Neuropeptide Y Receptor Sales Forecast by Application (2021-2026)
5.2.2 Global Neuropeptide Y Receptor Revenue Forecast by Application (2021-2026)
5.2.3 Global Neuropeptide Y Receptor Price Forecast by Application (2021-2026)
6 North America
6.1 North America Neuropeptide Y Receptor by Country
6.1.1 North America Neuropeptide Y Receptor Sales by Country
6.1.2 North America Neuropeptide Y Receptor Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Neuropeptide Y Receptor Market Facts & Figures by Type
6.3 North America Neuropeptide Y Receptor Market Facts & Figures by Application
7 Europe
7.1 Europe Neuropeptide Y Receptor by Country
7.1.1 Europe Neuropeptide Y Receptor Sales by Country
7.1.2 Europe Neuropeptide Y Receptor Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Neuropeptide Y Receptor Market Facts & Figures by Type
7.3 Europe Neuropeptide Y Receptor Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Neuropeptide Y Receptor by Region
8.1.1 Asia Pacific Neuropeptide Y Receptor Sales by Region
8.1.2 Asia Pacific Neuropeptide Y Receptor Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Neuropeptide Y Receptor Market Facts & Figures by Type
8.3 Asia Pacific Neuropeptide Y Receptor Market Facts & Figures by Application
9 Latin America
9.1 Latin America Neuropeptide Y Receptor by Country
9.1.1 Latin America Neuropeptide Y Receptor Sales by Country
9.1.2 Latin America Neuropeptide Y Receptor Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Neuropeptide Y Receptor Market Facts & Figures by Type
9.3 Central & South America Neuropeptide Y Receptor Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Neuropeptide Y Receptor by Country
10.1.1 Middle East and Africa Neuropeptide Y Receptor Sales by Country
10.1.2 Middle East and Africa Neuropeptide Y Receptor Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Neuropeptide Y Receptor Market Facts & Figures by Type
10.3 Middle East and Africa Neuropeptide Y Receptor Market Facts & Figures by Application
11 Company Profiles
11.1 Gila Therapeutics
11.1.1 Gila Therapeutics Corporation Information
11.1.2 Gila Therapeutics Description and Business Overview
11.1.3 Gila Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Gila Therapeutics Neuropeptide Y Receptor Products Offered
11.1.5 Gila Therapeutics Related Developments
11.2 Novo Nordisk
11.2.1 Novo Nordisk Corporation Information
11.2.2 Novo Nordisk Description and Business Overview
11.2.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Novo Nordisk Neuropeptide Y Receptor Products Offered
11.2.5 Novo Nordisk Related Developments
11.3 XL-protein
11.3.1 XL-protein Corporation Information
11.3.2 XL-protein Description and Business Overview
11.3.3 XL-protein Sales, Revenue and Gross Margin (2015-2020)
11.3.4 XL-protein Neuropeptide Y Receptor Products Offered
11.3.5 XL-protein Related Developments
11.4 Lilly Eli
11.4.1 Lilly Eli Corporation Information
11.4.2 Lilly Eli Description and Business Overview
11.4.3 Lilly Eli Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Lilly Eli Neuropeptide Y Receptor Products Offered
11.4.5 Lilly Eli Related Developments
11.5 Novartis
11.5.1 Novartis Corporation Information
11.5.2 Novartis Description and Business Overview
11.5.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Novartis Neuropeptide Y Receptor Products Offered
11.5.5 Novartis Related Developments
11.6 Pfizer
11.6.1 Pfizer Corporation Information
11.6.2 Pfizer Description and Business Overview
11.6.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Pfizer Neuropeptide Y Receptor Products Offered
11.6.5 Pfizer Related Developments
11.7 Merck & Co
11.7.1 Merck & Co Corporation Information
11.7.2 Merck & Co Description and Business Overview
11.7.3 Merck & Co Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Merck & Co Neuropeptide Y Receptor Products Offered
11.7.5 Merck & Co Related Developments
11.8 Mannkind
11.8.1 Mannkind Corporation Information
11.8.2 Mannkind Description and Business Overview
11.8.3 Mannkind Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Mannkind Neuropeptide Y Receptor Products Offered
11.8.5 Mannkind Related Developments
11.9 Gilead Sciences
11.9.1 Gilead Sciences Corporation Information
11.9.2 Gilead Sciences Description and Business Overview
11.9.3 Gilead Sciences Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Gilead Sciences Neuropeptide Y Receptor Products Offered
11.9.5 Gilead Sciences Related Developments
11.10 Genentech
11.10.1 Genentech Corporation Information
11.10.2 Genentech Description and Business Overview
11.10.3 Genentech Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Genentech Neuropeptide Y Receptor Products Offered
11.10.5 Genentech Related Developments
11.1 Gila Therapeutics
11.1.1 Gila Therapeutics Corporation Information
11.1.2 Gila Therapeutics Description and Business Overview
11.1.3 Gila Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Gila Therapeutics Neuropeptide Y Receptor Products Offered
11.1.5 Gila Therapeutics Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Neuropeptide Y Receptor Market Estimates and Projections by Region
12.1.1 Global Neuropeptide Y Receptor Sales Forecast by Regions 2021-2026
12.1.2 Global Neuropeptide Y Receptor Revenue Forecast by Regions 2021-2026
12.2 North America Neuropeptide Y Receptor Market Size Forecast (2021-2026)
12.2.1 North America: Neuropeptide Y Receptor Sales Forecast (2021-2026)
12.2.2 North America: Neuropeptide Y Receptor Revenue Forecast (2021-2026)
12.2.3 North America: Neuropeptide Y Receptor Market Size Forecast by Country (2021-2026)
12.3 Europe Neuropeptide Y Receptor Market Size Forecast (2021-2026)
12.3.1 Europe: Neuropeptide Y Receptor Sales Forecast (2021-2026)
12.3.2 Europe: Neuropeptide Y Receptor Revenue Forecast (2021-2026)
12.3.3 Europe: Neuropeptide Y Receptor Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Neuropeptide Y Receptor Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Neuropeptide Y Receptor Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Neuropeptide Y Receptor Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Neuropeptide Y Receptor Market Size Forecast by Region (2021-2026)
12.5 Latin America Neuropeptide Y Receptor Market Size Forecast (2021-2026)
12.5.1 Latin America: Neuropeptide Y Receptor Sales Forecast (2021-2026)
12.5.2 Latin America: Neuropeptide Y Receptor Revenue Forecast (2021-2026)
12.5.3 Latin America: Neuropeptide Y Receptor Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Neuropeptide Y Receptor Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Neuropeptide Y Receptor Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Neuropeptide Y Receptor Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Neuropeptide Y Receptor Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Neuropeptide Y Receptor Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Neuropeptide Y Receptor Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Neuropeptide Y Receptor Market Segments
Table 2. Ranking of Global Top Neuropeptide Y Receptor Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Neuropeptide Y Receptor Market Size Growth Rate by Type 2020-2026 (Kiloton) & (US$ Million)
Table 4. Major Manufacturers of Food Grade
Table 5. Major Manufacturers of Pharmaceutical Grade
Table 6. Global Neuropeptide Y Receptor Market Size Growth Rate by Application 2020-2026 (Kiloton)
Table 7. Global Neuropeptide Y Receptor Market Size by Region (Kiloton) & (US$ Million): 2020 VS 2026
Table 8. Global Neuropeptide Y Receptor Sales by Regions 2015-2020 (Kiloton)
Table 9. Global Neuropeptide Y Receptor Sales Market Share by Regions (2015-2020)
Table 10. Global Neuropeptide Y Receptor Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Neuropeptide Y Receptor Sales by Manufacturers (2015-2020) (Kiloton)
Table 12. Global Neuropeptide Y Receptor Sales Share by Manufacturers (2015-2020)
Table 13. Global Neuropeptide Y Receptor Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Neuropeptide Y Receptor by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neuropeptide Y Receptor as of 2019)
Table 15. Neuropeptide Y Receptor Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Neuropeptide Y Receptor Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Neuropeptide Y Receptor Price (2015-2020) (US$/Ton)
Table 18. Neuropeptide Y Receptor Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Neuropeptide Y Receptor Product Type
Table 20. Date of International Manufacturers Enter into Neuropeptide Y Receptor Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Neuropeptide Y Receptor Sales by Type (2015-2020) (Kiloton)
Table 23. Global Neuropeptide Y Receptor Sales Share by Type (2015-2020)
Table 24. Global Neuropeptide Y Receptor Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Neuropeptide Y Receptor Revenue Share by Type (2015-2020)
Table 26. Neuropeptide Y Receptor Average Selling Price (ASP) by Type 2015-2020 (US$/Ton)
Table 27. Global Neuropeptide Y Receptor Sales by Application (2015-2020) (Kiloton)
Table 28. Global Neuropeptide Y Receptor Sales Share by Application (2015-2020)
Table 29. North America Neuropeptide Y Receptor Sales by Country (2015-2020) (Kiloton)
Table 30. North America Neuropeptide Y Receptor Sales Market Share by Country (2015-2020)
Table 31. North America Neuropeptide Y Receptor Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Neuropeptide Y Receptor Revenue Market Share by Country (2015-2020)
Table 33. North America Neuropeptide Y Receptor Sales by Type (2015-2020) (Kiloton)
Table 34. North America Neuropeptide Y Receptor Sales Market Share by Type (2015-2020)
Table 35. North America Neuropeptide Y Receptor Sales by Application (2015-2020) (Kiloton)
Table 36. North America Neuropeptide Y Receptor Sales Market Share by Application (2015-2020)
Table 37. Europe Neuropeptide Y Receptor Sales by Country (2015-2020) (Kiloton)
Table 38. Europe Neuropeptide Y Receptor Sales Market Share by Country (2015-2020)
Table 39. Europe Neuropeptide Y Receptor Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Neuropeptide Y Receptor Revenue Market Share by Country (2015-2020)
Table 41. Europe Neuropeptide Y Receptor Sales by Type (2015-2020) (Kiloton)
Table 42. Europe Neuropeptide Y Receptor Sales Market Share by Type (2015-2020)
Table 43. Europe Neuropeptide Y Receptor Sales by Application (2015-2020) (Kiloton)
Table 44. Europe Neuropeptide Y Receptor Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Neuropeptide Y Receptor Sales by Region (2015-2020) (Kiloton)
Table 46. Asia Pacific Neuropeptide Y Receptor Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Neuropeptide Y Receptor Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Neuropeptide Y Receptor Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Neuropeptide Y Receptor Sales by Type (2015-2020) (Kiloton)
Table 50. Asia Pacific Neuropeptide Y Receptor Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Neuropeptide Y Receptor Sales by Application (2015-2020) (Kiloton)
Table 52. Asia Pacific Neuropeptide Y Receptor Sales Market Share by Application (2015-2020)
Table 53. Latin America Neuropeptide Y Receptor Sales by Country (2015-2020) (Kiloton)
Table 54. Latin America Neuropeptide Y Receptor Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Neuropeptide Y Receptor Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Neuropeptide Y Receptor Revenue Market Share by Country (2015-2020)
Table 57. Latin America Neuropeptide Y Receptor Sales by Type (2015-2020) (Kiloton)
Table 58. Latin America Neuropeptide Y Receptor Sales Market Share by Type (2015-2020)
Table 59. Latin America Neuropeptide Y Receptor Sales by Application (2015-2020) (Kiloton)
Table 60. Latin America Neuropeptide Y Receptor Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Neuropeptide Y Receptor Sales by Country (2015-2020) (Kiloton)
Table 62. Middle East and Africa Neuropeptide Y Receptor Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Neuropeptide Y Receptor Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Neuropeptide Y Receptor Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Neuropeptide Y Receptor Sales by Type (2015-2020) (Kiloton)
Table 66. Middle East and Africa Neuropeptide Y Receptor Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Neuropeptide Y Receptor Sales by Application (2015-2020) (Kiloton)
Table 68. Middle East and Africa Neuropeptide Y Receptor Sales Market Share by Application (2015-2020)
Table 69. Gila Therapeutics Corporation Information
Table 70. Gila Therapeutics Description and Major Businesses
Table 71. Gila Therapeutics Neuropeptide Y Receptor Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 72. Gila Therapeutics Product
Table 73. Gila Therapeutics Recent Development
Table 74. Novo Nordisk Corporation Information
Table 75. Novo Nordisk Description and Major Businesses
Table 76. Novo Nordisk Neuropeptide Y Receptor Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 77. Novo Nordisk Product
Table 78. Novo Nordisk Recent Development
Table 79. XL-protein Corporation Information
Table 80. XL-protein Description and Major Businesses
Table 81. XL-protein Neuropeptide Y Receptor Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 82. XL-protein Product
Table 83. XL-protein Recent Development
Table 84. Lilly Eli Corporation Information
Table 85. Lilly Eli Description and Major Businesses
Table 86. Lilly Eli Neuropeptide Y Receptor Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 87. Lilly Eli Product
Table 88. Lilly Eli Recent Development
Table 89. Novartis Corporation Information
Table 90. Novartis Description and Major Businesses
Table 91. Novartis Neuropeptide Y Receptor Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 92. Novartis Product
Table 93. Novartis Recent Development
Table 94. Pfizer Corporation Information
Table 95. Pfizer Description and Major Businesses
Table 96. Pfizer Neuropeptide Y Receptor Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 97. Pfizer Product
Table 98. Pfizer Recent Development
Table 99. Merck & Co Corporation Information
Table 100. Merck & Co Description and Major Businesses
Table 101. Merck & Co Neuropeptide Y Receptor Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 102. Merck & Co Product
Table 103. Merck & Co Recent Development
Table 104. Mannkind Corporation Information
Table 105. Mannkind Description and Major Businesses
Table 106. Mannkind Neuropeptide Y Receptor Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 107. Mannkind Product
Table 108. Mannkind Recent Development
Table 109. Gilead Sciences Corporation Information
Table 110. Gilead Sciences Description and Major Businesses
Table 111. Gilead Sciences Neuropeptide Y Receptor Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 112. Gilead Sciences Product
Table 113. Gilead Sciences Recent Development
Table 114. Genentech Corporation Information
Table 115. Genentech Description and Major Businesses
Table 116. Genentech Neuropeptide Y Receptor Production (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2015-2020)
Table 117. Genentech Product
Table 118. Genentech Recent Development
Table 119. Global Neuropeptide Y Receptor Sales Forecast by Regions (2021-2026) (Kiloton)
Table 120. Global Neuropeptide Y Receptor Sales Market Share Forecast by Regions (2021-2026)
Table 121. Global Neuropeptide Y Receptor Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 122. Global Neuropeptide Y Receptor Revenue Market Share Forecast by Regions (2021-2026)
Table 123. North America: Neuropeptide Y Receptor Sales Forecast by Country (2021-2026) (Kiloton)
Table 124. North America: Neuropeptide Y Receptor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Europe: Neuropeptide Y Receptor Sales Forecast by Country (2021-2026) (Kiloton)
Table 126. Europe: Neuropeptide Y Receptor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Asia Pacific: Neuropeptide Y Receptor Sales Forecast by Region (2021-2026) (Kiloton)
Table 128. Asia Pacific: Neuropeptide Y Receptor Revenue Forecast by Region (2021-2026) (US$ Million)
Table 129. Latin America: Neuropeptide Y Receptor Sales Forecast by Country (2021-2026) (Kiloton)
Table 130. Latin America: Neuropeptide Y Receptor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Middle East and Africa: Neuropeptide Y Receptor Sales Forecast by Country (2021-2026) (Kiloton)
Table 132. Middle East and Africa: Neuropeptide Y Receptor Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 134. Key Challenges
Table 135. Market Risks
Table 136. Main Points Interviewed from Key Neuropeptide Y Receptor Players
Table 137. Neuropeptide Y Receptor Customers List
Table 138. Neuropeptide Y Receptor Distributors List
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Neuropeptide Y Receptor Product Picture
Figure 2. Global Neuropeptide Y Receptor Sales Market Share by Type in 2020 & 2026
Figure 3. Food Grade Product Picture
Figure 4. Pharmaceutical Grade Product Picture
Figure 5. Global Neuropeptide Y Receptor Sales Market Share by Application in 2020 & 2026
Figure 6. Medicine
Figure 7. Food Additives
Figure 8. Others
Figure 9. Neuropeptide Y Receptor Report Years Considered
Figure 10. Global Neuropeptide Y Receptor Market Size 2015-2026 (US$ Million)
Figure 11. Global Neuropeptide Y Receptor Sales 2015-2026 (Kiloton)
Figure 12. Global Neuropeptide Y Receptor Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Neuropeptide Y Receptor Sales Market Share by Region (2015-2020)
Figure 14. Global Neuropeptide Y Receptor Sales Market Share by Region in 2019
Figure 15. Global Neuropeptide Y Receptor Revenue Market Share by Region (2015-2020)
Figure 16. Global Neuropeptide Y Receptor Revenue Market Share by Region in 2019
Figure 17. Global Neuropeptide Y Receptor Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Neuropeptide Y Receptor Revenue in 2019
Figure 19. Neuropeptide Y Receptor Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Neuropeptide Y Receptor Sales Market Share by Type (2015-2020)
Figure 21. Global Neuropeptide Y Receptor Sales Market Share by Type in 2019
Figure 22. Global Neuropeptide Y Receptor Revenue Market Share by Type (2015-2020)
Figure 23. Global Neuropeptide Y Receptor Revenue Market Share by Type in 2019
Figure 24. Global Neuropeptide Y Receptor Market Share by Price Range (2015-2020)
Figure 25. Global Neuropeptide Y Receptor Sales Market Share by Application (2015-2020)
Figure 26. Global Neuropeptide Y Receptor Sales Market Share by Application in 2019
Figure 27. Global Neuropeptide Y Receptor Revenue Market Share by Application (2015-2020)
Figure 28. Global Neuropeptide Y Receptor Revenue Market Share by Application in 2019
Figure 29. North America Neuropeptide Y Receptor Sales Growth Rate 2015-2020 (Kiloton)
Figure 30. North America Neuropeptide Y Receptor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Neuropeptide Y Receptor Sales Market Share by Country in 2019
Figure 32. North America Neuropeptide Y Receptor Revenue Market Share by Country in 2019
Figure 33. U.S. Neuropeptide Y Receptor Sales Growth Rate (2015-2020) (Kiloton)
Figure 34. U.S. Neuropeptide Y Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Neuropeptide Y Receptor Sales Growth Rate (2015-2020) (Kiloton)
Figure 36. Canada Neuropeptide Y Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Neuropeptide Y Receptor Market Share by Type in 2019
Figure 38. North America Neuropeptide Y Receptor Market Share by Application in 2019
Figure 39. Europe Neuropeptide Y Receptor Sales Growth Rate 2015-2020 (Kiloton)
Figure 40. Europe Neuropeptide Y Receptor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Neuropeptide Y Receptor Sales Market Share by Country in 2019
Figure 42. Europe Neuropeptide Y Receptor Revenue Market Share by Country in 2019
Figure 43. Germany Neuropeptide Y Receptor Sales Growth Rate (2015-2020) (Kiloton)
Figure 44. Germany Neuropeptide Y Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Neuropeptide Y Receptor Sales Growth Rate (2015-2020) (Kiloton)
Figure 46. France Neuropeptide Y Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Neuropeptide Y Receptor Sales Growth Rate (2015-2020) (Kiloton)
Figure 48. U.K. Neuropeptide Y Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Neuropeptide Y Receptor Sales Growth Rate (2015-2020) (Kiloton)
Figure 50. Italy Neuropeptide Y Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Neuropeptide Y Receptor Sales Growth Rate (2015-2020) (Kiloton)
Figure 52. Russia Neuropeptide Y Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Neuropeptide Y Receptor Market Share by Type in 2019
Figure 54. Europe Neuropeptide Y Receptor Market Share by Application in 2019
Figure 55. Asia Pacific Neuropeptide Y Receptor Sales Growth Rate 2015-2020 (Kiloton)
Figure 56. Asia Pacific Neuropeptide Y Receptor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Neuropeptide Y Receptor Sales Market Share by Region in 2019
Figure 58. Asia Pacific Neuropeptide Y Receptor Revenue Market Share by Region in 2019
Figure 59. China Neuropeptide Y Receptor Sales Growth Rate (2015-2020) (Kiloton)
Figure 60. China Neuropeptide Y Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Neuropeptide Y Receptor Sales Growth Rate (2015-2020) (Kiloton)
Figure 62. Japan Neuropeptide Y Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Neuropeptide Y Receptor Sales Growth Rate (2015-2020) (Kiloton)
Figure 64. South Korea Neuropeptide Y Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Neuropeptide Y Receptor Sales Growth Rate (2015-2020) (Kiloton)
Figure 66. India Neuropeptide Y Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Neuropeptide Y Receptor Sales Growth Rate (2015-2020) (Kiloton)
Figure 68. Australia Neuropeptide Y Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Neuropeptide Y Receptor Sales Growth Rate (2015-2020) (Kiloton)
Figure 70. Taiwan Neuropeptide Y Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Neuropeptide Y Receptor Sales Growth Rate (2015-2020) (Kiloton)
Figure 72. Indonesia Neuropeptide Y Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Neuropeptide Y Receptor Sales Growth Rate (2015-2020) (Kiloton)
Figure 74. Thailand Neuropeptide Y Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Neuropeptide Y Receptor Sales Growth Rate (2015-2020) (Kiloton)
Figure 76. Malaysia Neuropeptide Y Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Neuropeptide Y Receptor Sales Growth Rate (2015-2020) (Kiloton)
Figure 78. Philippines Neuropeptide Y Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Neuropeptide Y Receptor Sales Growth Rate (2015-2020) (Kiloton)
Figure 80. Vietnam Neuropeptide Y Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Neuropeptide Y Receptor Market Share by Type in 2019
Figure 82. Asia Pacific Neuropeptide Y Receptor Market Share by Application in 2019
Figure 83. Latin America Neuropeptide Y Receptor Sales Growth Rate 2015-2020 (Kiloton)
Figure 84. Latin America Neuropeptide Y Receptor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Neuropeptide Y Receptor Sales Market Share by Country in 2019
Figure 86. Latin America Neuropeptide Y Receptor Revenue Market Share by Country in 2019
Figure 87. Mexico Neuropeptide Y Receptor Sales Growth Rate (2015-2020) (Kiloton)
Figure 88. Mexico Neuropeptide Y Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Neuropeptide Y Receptor Sales Growth Rate (2015-2020) (Kiloton)
Figure 90. Brazil Neuropeptide Y Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Neuropeptide Y Receptor Sales Growth Rate (2015-2020) (Kiloton)
Figure 92. Argentina Neuropeptide Y Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Neuropeptide Y Receptor Market Share by Type in 2019
Figure 94. Latin America Neuropeptide Y Receptor Market Share by Application in 2019
Figure 95. Middle East and Africa Neuropeptide Y Receptor Sales Growth Rate 2015-2020 (Kiloton)
Figure 96. Middle East and Africa Neuropeptide Y Receptor Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Neuropeptide Y Receptor Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Neuropeptide Y Receptor Revenue Market Share by Country in 2019
Figure 99. Turkey Neuropeptide Y Receptor Sales Growth Rate (2015-2020) (Kiloton)
Figure 100. Turkey Neuropeptide Y Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Neuropeptide Y Receptor Sales Growth Rate (2015-2020) (Kiloton)
Figure 102. Saudi Arabia Neuropeptide Y Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. UAE Neuropeptide Y Receptor Sales Growth Rate (2015-2020) (Kiloton)
Figure 104. UAE Neuropeptide Y Receptor Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Neuropeptide Y Receptor Market Share by Type in 2019
Figure 106. Middle East and Africa Neuropeptide Y Receptor Market Share by Application in 2019
Figure 107. North America Neuropeptide Y Receptor Sales Growth Rate Forecast (2021-2026) (Kiloton)
Figure 108. North America Neuropeptide Y Receptor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Neuropeptide Y Receptor Sales Growth Rate Forecast (2021-2026) (Kiloton)
Figure 110. Europe Neuropeptide Y Receptor Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Neuropeptide Y Receptor Sales Growth Rate Forecast (2021-2026) (Kiloton)
Figure 112. Asia
  • Global Sunflower Oilseed Processing Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Sunflower Oilseed Processing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Sunflower Oilseed Processing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Sunflower Oilseed Processing is estimated to increase from $ million i......
  • Global Rapeseed Oilseed Processing Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Rapeseed Oilseed Processing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Rapeseed Oilseed Processing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Rapeseed Oilseed Processing is estimated to increase from $ million in 2......
  • Global Premium Cheese Powder Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Premium Cheese Powder market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Premium Cheese Powder is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Premium Cheese Powder is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Poultry and Seafood Packaging Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 107
    The global Poultry and Seafood Packaging market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. According to Our PET Supplies Research Center, The global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains The highest pet penetration rate and becomes The largest pet market. According to The American Pet Products Association (APPA), 66% of ......
  • Global Fibers & Specialty Carbohydrate Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Fibers & Specialty Carbohydrate market was valued at US$ 921.2 million in 2023 and is anticipated to reach US$ 1267.2 million by 2030, witnessing a CAGR of 3.7% during The forecast period 2024-2030. North American market for Fibers & Specialty Carbohydrate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Fibers & Specialty Carbohydrate is estimated to ......
  • Global Nutritional & Dietary Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 99
    The global Nutritional & Dietary Supplements market was valued at US$ 420.2 million in 2023 and is anticipated to reach US$ 586.6 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. North American market for Nutritional & Dietary Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Nutritional & Dietary Supplements is estimate......
  • Global Seafood Safety Testing Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 92
    The global Seafood Safety Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Seafood Safety Testing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Seafood Safety Testing is estimated to increase from $ million in 2023 to reach $ ......
  • Global Seasonal Candy Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 104
    The global Seasonal Candy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Seasonal Candy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Seasonal Candy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CA......
  • Global Ready-to-drink Protein Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 91
    The ready-to-drink protein beverages are products produced using a variety of high-protein substances to fulfill The daily nutrient requirements of individuals and are considered a convenient way to consume nutrients on The go. The global Ready-to-drink Protein market was valued at US$ 1403 million in 2023 and is anticipated to reach US$ 1929.3 million by 2030, witnessing a CAGR of 4.6% during The forecast period 2024-2030. North American market for Ready-to-drink Prote......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs